Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. Common warts are characterized by a rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the footprint pattern.

The drug is both safe and effective for the removal of these types of warts.

No teratogenic or nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be carefully applied to each wart, ensuring that the entire wart is sufficiently covered. It is important to allow the application to dry completely before proceeding.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product due to the increased risk of complications. Application is also contraindicated on genital warts, warts located on the face, or mucous membranes, as well as on moles, birthmarks, or warts with hair growth. Additionally, the product should not be applied to irritated skin or any area that is infected or exhibits redness, as this may exacerbate the condition.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

This product is contraindicated for individuals with diabetes or those who exhibit poor blood circulation. It should not be applied to genital warts, warts located on the face, or any mucous membranes. Additionally, it is not suitable for use on moles, birthmarks, or warts that have hair growing from them. Application on irritated skin or any area that is infected or reddened is also prohibited.

When using this product, it is essential to take specific precautions. In the event that the product comes into contact with the eyes, it is crucial to flush the eyes with water for at least 15 minutes. Users should avoid inhaling vapors to minimize respiratory irritation. The bottle should be capped tightly after use and stored at room temperature, away from heat sources.

If discomfort persists after application, users are advised to discontinue use and consult a healthcare professional. It is imperative to keep this product out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that this product is for external use only. It is contraindicated in individuals who are diabetic or have poor blood circulation. Additionally, the product should not be applied to genital warts, warts on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. It is also not recommended for use on irritated skin or any area that is infected or reddened.

During the use of this product, if it comes into contact with the eyes, it is essential to flush the eyes with water for 15 minutes. Patients should avoid inhaling vapors and ensure that the bottle is capped tightly and stored at room temperature, away from heat sources.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (liquid wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

Pregnant patients should not use this product if they have diabetes or poor blood circulation. The safety of this product during pregnancy has not been established, and it is contraindicated for use on genital warts, warts on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be applied to irritated skin or any area that is infected or reddened. This product is intended for external use only and is flammable; therefore, it should be kept away from fire or flame. Healthcare professionals should exercise caution and consider alternative treatments for pregnant patients.

Lactation

There is no information available regarding the use of Salicylic Acid Liquid Wart Remover in lactating mothers or any lactation considerations. Consequently, the effects on breastfed infants and the excretion of the drug in breast milk are not established. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control and emergency medical services is recommended to ensure optimal management and patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for individuals with diabetes or poor blood circulation. Additionally, it should not be used on genital warts, warts located on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. It is also important to instruct patients not to apply the product on irritated skin or any area that appears infected or reddened.

When using this product, patients should be cautioned to avoid contact with the eyes; if the product does get into the eyes, they should flush with water for at least 15 minutes. Patients should also be advised to avoid inhaling vapors and to ensure that the bottle is capped tightly and stored at room temperature, away from heat sources.

Finally, healthcare providers should instruct patients to discontinue use and consult a doctor if discomfort persists.

Storage and Handling

The product is supplied in a container that must be stored at a temperature range of 20°C to 25°C (68°F to 77°F). It is essential to keep the container tightly closed to prevent solidification. After each use, the top of the bottle should be wiped clean to maintain hygiene and product integrity.

Care should be taken to avoid contact with surrounding skin during application. Additionally, the product should not come into contact with fabrics, floors, countertops, or other surfaces, as it may cause staining. It is also important to keep the product away from fire or flame. The product should be discarded when signs of the wart no longer appear.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)